Problems of complex use of bacteriophages for prevention and treatment


DOI: https://dx.doi.org/10.18565/epidem.2018.3.11-5

Brusina E.В., Drozdova O.M., Aleshkin A.V., Shagin D.A., Tutelian A.V., Akimkin V.G.

1 Kemerovo State Medical University, Ministry of Health of Russia, Kemerovo, Russia; 2 G.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 3 Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Customers Rights and Human Well-Being, Moscow, Russia
Bacteriophages are alternative medicines to overcome the problem of the global spread of multidrug- and pandrug-resistant strains to antimicrobial agents. The priority developments in the use of bacteriophages, which were made in the Soviet Union in the 1970s and 1980s, have shown their high epidemiological efficacy and prospects for using these drugs in the fight against infections. At the same time, the requirements for the biological safety of drugs and for medical care determine the need to consider a number of aspects that prevent the use of bacteriophages. The paper considers the problems that limit the use of bacteriophages in medicine.
Keywords: biological disinfection, phagotherapy, bacteriophages
Read entire article

Literature

  1. G20 Leaders’ Declaration: Shaping an interconnected world (Hamburg, 7/8 July 2017). URL: https://www.g20.org/en/g20/timeline
  2. Aleshkin A.V., Sel’kova E.P., Ershova O.N., Shkoda A.S., Bochkareva S.S., Mitrohin S.D., Kiseleva I.A., Orlova O.E., Rubal’skij E.O., Zul’karneev E.R. [Concept of personalized phage therapy for intensive care unit patients with healthcare-associated infections]. Fundamental’naуa i klinicheskaуa medicina 2018; 3(2): 66–74. DOI: 10.23946/2500-0764-2018-3-2-66-74 (In Russ.).
  3. Drozdova O.M., Brusina E.B. [Use of bacteriophages in epidemiological practice: a view after a century]. Epidemiologiуa i infekcionnye bolezni 2010; (5): 20–4. (In Russ.).
  4. Kostуukevich O.I. [The use of bacteriophages in clinical practice: the Renaissance]. Russkiy meditsinskiy zhurnal 2015; (21): 1258–62. (In Russ.).
  5. Akimkin V.G., Shestopalova T.N., Brusina E.B. [The development of the bacteriophages biological disinfection method in the focci of healthcare-associated infections]. Infekcionnye bolezni 2016; 14(S1): 315. (In Russ.).
  6. Brusina E., Drozdova O., Zueva L., Akimkin V., Fedorova L. Complex application of bacteriophages as a method of healthcare-associated infections control. Antimicrob. Resist. Infect. Control 2015, 4(Suppl 1): 46. URL: http://www.aricjournal.com/content/4/S1/P46
  7. Brusina E.B., Drozdova O.M., Kutikhin A.G. A new method of bacteriophage-based disinfection in healthcare settings. 2013, 2(Suppl 1): O20. URL: http://www.aricjournal.com/content/2/S1/O20
  8. Metzker M.L. Sequencing technologies – the next generation. Nat. Rev. Genet. 2010; 11(1): 31–46. DOI: 10.1038/nrg2626.
  9. Penadés J.R., Chen J., Quiles-Puchalt N., Carpena N., Novick R.P. Bacteriophage-mediated spread of bacterial virulence genes. Curr. Opin. Microbiol. 2015: 171–8. DOI: 10.1016/j.mib.2014.11.019.
  10. Modi S.R., Lee H.H., Spina C.S., Collins J.J. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 2013; 499(7457): 219–22. DOI: 10.1038/nature12212.
  11. Colomer-Lluch M., Jofre J., Muniesa M. Antibiotic resistance genes in the bacteriophage DNA fraction of environmental samples. PLoS One 2011; 6(3): e17549. DOI: 10.1371/journal.pone.0017549.

For citations: Brusina E.В., Drozdova O.M., Aleshkin A.V., Shagin D.A., Tutelian A.V., Akimkin V.G. Problems of complex use of bacteriophages for prevention and treatment. Èpidemiologiâ i infekcionnye bolezni. Аktual’nye voprosy 2018; (3):11–5


About the Autors

For correspondence:
Prof. Elena B. Brusina, MD, Head, Department of Epidemiology, Kemerovo State Medical University, Ministry of Health of Russia
Address: 22a, Voroshilov St., Kemerovo 650056, Russia
Telephone: +7(3842) 25-59-15
E-mail: brusina@mail.ru
ОRCID: http://orcid.org/0000-0002-8616-3227
Information about the authors:
Prof. Olga M. Drozdova, MD, Professor, Department of Epidemiology, Kemerovo State Medical University, Ministry of Health of Russia, Kemerovo, Russia; e-mail: om-drozdova@mail.ru
Andrei V. Aleshkin, BD, Head, Laboratory for Clinical Microbiology and Biotechnology of Bacteriophages, G.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: andreialeshkin@googlemail.com; ORCID: http://orcid.org/0000-0002-0532-1378
Dmitry A. Shagin, Cand. Biol. Sci., Senior Researcher, Department for Molecular Diagnosis and Epidemiology of Bacteriophages, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: shagdim777@gmail.com; ОRCID: http://orcid.org/0000-0002-9468-6140
Prof. Alexey V. Tutelian, MD, Corresponding Member of the Russian Academy of Sciences, Head, Laboratory for Healthcare-Associated Infections, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: bio-tav@yandex.ru;
Prof. Vasiliy G. Akimkin, MD, Аcademician of the Russian Academy of Sciences, Director, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: vgakimkin@yandex.ru; Scopus Author ID: 6603947364; ОRCID: http://orcid.org/0000-0003-4228-9044;


Similar Articles

Back to Content

Бионика Медиа